Keros Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Keros Therapeutics, Inc. (KROS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 154.14 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-03
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 44.46K shares, a 202.99% increase year-over-year.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 109.68K shares.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 600.00K shares, a 39608.93% increase year-over-year.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 95.23K shares, a 728.14% increase year-over-year.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 709.90K shares, a 2523.44% increase from fiscal 2024.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 27.06K shares, a 11.05% decline from fiscal 2023.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 30.42K shares, a 195.06% increase from fiscal 2022.
- Keros Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 10.31K shares, a 649.82% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 44.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | 154.14K shares 10-Q · filed 2026-08-03 | 754.15K shares derived: sum of 3 quarters · filed 2026-08-03 | 849.37K shares derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 109.68K shares 10-Q · filed 2026-05-14 | 709.68K shares derived: sum of 2 quarters · filed 2026-05-14 | 804.91K shares derived: sum of 3 quarters · filed 2026-05-14 | 819.59K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 600.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 695.23K shares derived: sum of 2 quarters · filed 2026-03-04 | 709.90K shares derived: sum of 3 quarters · filed 2026-03-04 | 709.90K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 95.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 109.90K shares derived: sum of 2 quarters · filed 2025-11-05 | 109.90K shares 10-Q · filed 2025-11-05 | 111.41K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 14.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 14.67K shares 10-Q · filed 2025-08-06 | 16.18K shares derived: sum of 3 quarters · filed 2025-08-06 | 27.68K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | 1.51K shares derived: sum of 2 quarters · filed 2025-05-06 | 13.01K shares derived: sum of 3 quarters · filed 2025-05-06 | |
| 2024-12-31 | 1.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 13.01K shares derived: sum of 2 quarters · filed 2025-02-26 | 27.06K shares 10-K · filed 2025-02-26 | |
| 2024-09-30 | 11.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 25.55K shares 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | 14.05K shares 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | 6.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 22.65K shares derived: sum of 2 quarters · filed 2024-02-28 | 27.33K shares derived: sum of 3 quarters · filed 2024-02-28 | 30.42K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 16.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 20.70K shares derived: sum of 2 quarters · filed 2023-11-06 | 23.80K shares 10-Q · filed 2023-11-06 | 24.83K shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 4.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 7.77K shares 10-Q · filed 2023-08-07 | 8.80K shares derived: sum of 3 quarters · filed 2023-08-07 | 11.20K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 3.09K shares 10-Q · filed 2023-05-04 | 4.12K shares derived: sum of 2 quarters · filed 2023-05-04 | 6.53K shares derived: sum of 3 quarters · filed 2023-05-04 | -37.30K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 1.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | 3.44K shares derived: sum of 2 quarters · filed 2023-03-03 | -40.40K shares derived: sum of 3 quarters · filed 2023-03-03 | 10.31K shares 10-K · filed 2023-03-03 |
| 2022-09-30 | 2.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -41.42K shares derived: sum of 2 quarters · filed 2022-11-03 | 9.28K shares 10-Q · filed 2022-11-03 | -165.33K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -43.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 6.88K shares 10-Q · filed 2022-08-04 | -167.73K shares derived: sum of 3 quarters · filed 2022-08-04 | -18.48K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 50.70K shares 10-Q · filed 2022-05-05 | -123.90K shares derived: sum of 2 quarters · filed 2022-05-05 | 25.35K shares derived: sum of 3 quarters · filed 2022-05-05 | 25.35K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | -174.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -25.36K shares derived: sum of 2 quarters · filed 2022-03-09 | -25.36K shares derived: sum of 3 quarters · filed 2022-03-09 | 1.38K shares 10-K · filed 2022-03-09 |
| 2021-09-30 | 149.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 149.25K shares derived: sum of 2 quarters · filed 2021-11-04 | 175.98K shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 26.73K shares 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | 26.73K shares 10-Q · filed 2021-05-06 | |||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-10 | 3.03K shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 3.03K shares 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | 3.03K shares 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |